Pas de connexion internet — affichage de la version enregistrée de la page.

10x Genomics, Inc…

USUSD
← Vers le Screener
US:TXGLSE:0A88

10x Genomics, Inc. (US:TXG) — Biotechnology: Laboratory Analytical Instruments. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
10xgenomics.com
Secteur
Industrials · Biotechnology: Laboratory Analytical Instruments
Siège Social
Pleasanton, United States
PDG
Serge Saxonov
Employés
1 178
Fondée
2012
Actions en Circulation
120.21 M
Flottant
118.19 M
Capitalisation Boursière
11.53 Md USD
Initiés
1.46%
Investisseurs Institutionnels
120.2%
Secteur d'Activité (SIC)
Laboratory Analytical Instruments
ISIN
US88025U1097
LEI
5493003Z6741WNLG7H43
FCF
121 M USD
Dette
0 USD
trésorerie nette
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksTXG principaleUSD80.65 +4.36%actions ordinaires
LSE London Stock Exchange0A88 IOBUSD88.31 +0.00%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas
publicité

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
FMR, LLC14.67%17.63 M2026-06-30
Blackrock Inc.8.99%10.8 M2026-06-30
ARK Investment Managemen…8.32%10 M2026-06-30
Vanguard Portfolio Manag…5.81%6.98 M2026-06-30
Quantinno Capital Manage…4.55%5.47 M2026-06-30
Vanguard Capital Managem…4.23%5.08 M2026-06-30
Price (T.Rowe) Associate…3.78%4.54 M2026-06-30
Sumitomo Mitsui Trust Gr…3.49%4.19 M2026-06-30
Amova Asset Management A…3.49%4.19 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.94%3.53 M2026-06-30
Morgan Stanley2.79%3.35 M2026-06-30
iShares Trust-iShares Ru…2.53%3.04 M2026-07-31
ARK ETF Trust-ARK Genomi…2.53%3.04 M2026-08-31
ARK ETF Trust-ARK Innova…2.5%3.01 M2026-08-31
VANGUARD INDEX FUNDS-Van…2.12%2.55 M2026-06-30
Fidelity Select PORT.s-S…1.66%2 M2026-07-31
Fidelity Rutland Square…1.37%1.65 M2026-07-31
Fidelity Select Portfoli…1.34%1.61 M2026-07-31
VANGUARD INDEX FUNDS-Van…1.22%1.47 M2026-06-30
T. Rowe Price New Horizo…1.21%1.46 M2026-06-30
SAXONOV SERGE WILSON (Ch…≈1.11%1.34 M2026-09-22
HINDSON BENJAMIN J (Pres…≈0.41%488 1822026-08-24
STUELPNAGEL JOHN R (Dire…≈0.27%328 4362026-09-03
TAICH ADAM (Chief Financ…≈0.26%316 3442026-09-09
MATEO ALAN V. (Director)≈0.07%85 8772026-06-04
KOSARAJU SRIDHAR (Direct…≈0.06%68 2782026-06-04
POPOVITS KIMBERLY J (Dir…≈0.03%37 4452026-06-04
TEICHMANN SARAH A. (Dire…≈0.02%28 0582026-08-14
SULIMAN SHEHNAAZ (Direct…≈0.02%23 7922026-09-22